Every minute, 38 people are diagnosed with cancer, and 18 people die from it globally, according to the World Health ...

Myriad Genetics announces USPTO grants two new patents for its molecular residual disease assay: Salt Lake City Friday, February 7, 2025, 13:00 Hrs [IST] Myriad Genetics, Inc., a ...

Finding life on another planet would be a world-changing discovery for humanity. But actually detecting it is no simple task.

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and tumor genomic testing and precision medicine, announced that the United States Patent and ...

The platform enables direct, unbiased genome-wide identification and quantification of the exact position of double strand DNA breaks in edited cells.

India’s Parliament has been disrupted as opposition lawmakers protested the alleged mistreatment of 104 Indian immigrants ...

Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...

Myriad continues to develop its Precise MRD assay to meet the needs of patients with cancer, academic partners, and biopharma ...

Researchers at the University of Toronto have developed a novel approach to measure metabolites using DNA sequencing.

A new Weizmann Institute study identified all of the proteins in a stool sample – those from the microbiome, the human body and food – revealing the hidden secrets of the intestines and their impact o ...

Alida Biosciences (AlidaBio), an innovator in epigenomic research tools, today announced the full commercial launch of its EpiPlextm platform, the first to concurrently detect and quantify multiple ...

The Dovetail Certified Service Provider program sets stringent standards of proficiency and data quality that service labs ...